Disability Studies 2072F/G Chapter Notes - Chapter 3: Sequenom, Prenatal Diagnosis, Down Syndrome
8 Feb 2020
School
Department
Professor
Document Summary
A disability critique of the new prenatal test for down syndrome. A new test called maternit21 requires a maternal blood sample at 10 weeks gestation to test for. Down syndrome w/ 99. 1% sensitivity (identification) and 99. 9% specificity (gave the correct result) This is seen to be an improvement in prenatal testing because it increases accuracy and decreases the risk of miscarraige. Some recommend its use alongside amniocentesis - however it could replace amniocentesis and. There has been a discussion about the consequences of people with ds living in a culture where parents terminate fetuses with their genetic condition. The efforts of the developer of maternit21 are to create a greater demand for the testing. The current screening prenatal tests are supplemented with other modalities. Rates of refusal are different based on the population. Studies done on why women refuse prenatal testing suggest that maternit21 can address all of their concerns and increase the use of prenatal testing.
